Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Hereditary Angioedema Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
IBio Inc
CSL Limited
BioCryst Pharmaceuticals, Inc
Pharming Group NV
Shire plc
Ionis Pharmaceuticals, Inc
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Application:
Type I
Type II
Type III
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Hereditary Angioedema Drug Industry Overview
-
1.1.1 Hereditary Angioedema Drug Market Scope and Market Segments
-
1.1.2 Hereditary Angioedema Drug Industry Characteristics
-
1.1.3 Global and China Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Hereditary Angioedema Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Hereditary Angioedema Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 C1 Esterase Inhibitor
-
1.2.2 Kallikrein Inhibitor
-
1.2.3 Selective Bradykinin B2 Receptor Antagonist
-
1.3 Global Hereditary Angioedema Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Type I
-
1.3.2 Type II
-
1.3.3 Type III
-
1.4 Market Analysis by Region
-
1.4.1 North America Hereditary Angioedema Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Hereditary Angioedema Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Hereditary Angioedema Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Hereditary Angioedema Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Hereditary Angioedema Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Hereditary Angioedema Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Hereditary Angioedema Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Hereditary Angioedema Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Hereditary Angioedema Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Hereditary Angioedema Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Hereditary Angioedema Drug Industry PEST Analysis
-
2.3 Hereditary Angioedema Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Hereditary Angioedema Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Hereditary Angioedema Drug Industry
Chapter 3 Global and China Hereditary Angioedema Drug Market, by Manufacturer
-
3.1 Global and China Hereditary Angioedema Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Hereditary Angioedema Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Hereditary Angioedema Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Hereditary Angioedema Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Hereditary Angioedema Drug Market Top 3 Players
Chapter 4 Global and China Hereditary Angioedema Drug Market, by Type (2017-2028)
-
4.1 Hereditary Angioedema Drug Market Trend, by Type
-
4.2 Global Hereditary Angioedema Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Hereditary Angioedema Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Hereditary Angioedema Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Hereditary Angioedema Drug Price Trend, by Type (2017-2028)
-
4.3 China Hereditary Angioedema Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Hereditary Angioedema Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Hereditary Angioedema Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Hereditary Angioedema Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Hereditary Angioedema Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Hereditary Angioedema Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Hereditary Angioedema Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Hereditary Angioedema Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Hereditary Angioedema Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Hereditary Angioedema Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Hereditary Angioedema Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Hereditary Angioedema Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Hereditary Angioedema Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Hereditary Angioedema Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Hereditary Angioedema Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Hereditary Angioedema Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Hereditary Angioedema Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Hereditary Angioedema Drug Market Analysis
-
7.1 North America Hereditary Angioedema Drug Market, by Type
-
7.2 North America Hereditary Angioedema Drug Market, by Application
-
7.3 North America Hereditary Angioedema Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Hereditary Angioedema Drug Market Analysis
-
8.1 Europe Hereditary Angioedema Drug Market, by Type
-
8.2 Europe Hereditary Angioedema Drug Market, by Application
-
8.3 Europe Hereditary Angioedema Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Hereditary Angioedema Drug Market Analysis
-
9.1 APAC Hereditary Angioedema Drug Market, by Type
-
9.2 APAC Hereditary Angioedema Drug Market, by Application
-
9.3 APAC Hereditary Angioedema Drug Market Analysis and Forecast, by Country
-
9.3.1 China Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Hereditary Angioedema Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Hereditary Angioedema Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Hereditary Angioedema Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Hereditary Angioedema Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Hereditary Angioedema Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Hereditary Angioedema Drug Company Profiles
-
11.1 IBio Inc
-
11.1.1 IBio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 IBio Inc Hereditary Angioedema Drug Product Profiles, Application and Specification
-
11.1.3 IBio Inc Hereditary Angioedema Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 CSL Limited
-
11.2.1 CSL Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 CSL Limited Hereditary Angioedema Drug Product Profiles, Application and Specification
-
11.2.3 CSL Limited Hereditary Angioedema Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 BioCryst Pharmaceuticals, Inc
-
11.3.1 BioCryst Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 BioCryst Pharmaceuticals, Inc Hereditary Angioedema Drug Product Profiles, Application and Specification
-
11.3.3 BioCryst Pharmaceuticals, Inc Hereditary Angioedema Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Pharming Group NV
-
11.4.1 Pharming Group NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Pharming Group NV Hereditary Angioedema Drug Product Profiles, Application and Specification
-
11.4.3 Pharming Group NV Hereditary Angioedema Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Shire plc
-
11.5.1 Shire plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Shire plc Hereditary Angioedema Drug Product Profiles, Application and Specification
-
11.5.3 Shire plc Hereditary Angioedema Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Ionis Pharmaceuticals, Inc
-
11.6.1 Ionis Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Ionis Pharmaceuticals, Inc Hereditary Angioedema Drug Product Profiles, Application and Specification
-
11.6.3 Ionis Pharmaceuticals, Inc Hereditary Angioedema Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Hereditary Angioedema Drug Industry Investment Prospect and Risk Assessment
-
12.1 Hereditary Angioedema Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Hereditary Angioedema Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Hereditary Angioedema Drug Production Value and Growth Rate (2017-2028)
-
Figure China Hereditary Angioedema Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Hereditary Angioedema Drug Market Size and Growth Rate of C1 Esterase Inhibitor (2017-2028)
-
Figure Global Hereditary Angioedema Drug Market Size and Growth Rate of Kallikrein Inhibitor (2017-2028)
-
Figure Global Hereditary Angioedema Drug Market Size and Growth Rate of Selective Bradykinin B2 Receptor Antagonist (2017-2028)
-
Figure Global Hereditary Angioedema Drug Market Size and Growth Rate of Type I (2017-2028)
-
Figure Global Hereditary Angioedema Drug Market Size and Growth Rate of Type II (2017-2028)
-
Figure Global Hereditary Angioedema Drug Market Size and Growth Rate of Type III (2017-2028)
-
Figure North America Hereditary Angioedema Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Hereditary Angioedema Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Hereditary Angioedema Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Hereditary Angioedema Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Hereditary Angioedema Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Hereditary Angioedema Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Hereditary Angioedema Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Hereditary Angioedema Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Hereditary Angioedema Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Hereditary Angioedema Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Hereditary Angioedema Drug Market Share, by Manufacturer in 2022
-
Table Global Hereditary Angioedema Drug Sales Volume, by Type (2017-2028)
-
Table Global Hereditary Angioedema Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Hereditary Angioedema Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Hereditary Angioedema Drug Sales Value, by Type (2017-2028)
-
Table Global Hereditary Angioedema Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Hereditary Angioedema Drug Price Trend, by Type (2017-2028)
-
Table China Hereditary Angioedema Drug Sales Volume, by Type (2017-2028)
-
Table China Hereditary Angioedema Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Hereditary Angioedema Drug Sales Volume Share, by Type (2017-2028)
-
Table China Hereditary Angioedema Drug Sales Value, by Type (2017-2028)
-
Table China Hereditary Angioedema Drug Sales Value Share, by Type (2017-2028)
-
Figure China Hereditary Angioedema Drug Price Trend, by Type (2017-2028)
-
Table Global Hereditary Angioedema Drug Sales Volume, by Application (2017-2028)
-
Table Global Hereditary Angioedema Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Hereditary Angioedema Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Hereditary Angioedema Drug Sales Value, by Application (2017-2028)
-
Table Global Hereditary Angioedema Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Hereditary Angioedema Drug Sales Value Share, by Application (2017-2028)
-
Table China Hereditary Angioedema Drug Sales Volume, by Application (2017-2028)
-
Table China Hereditary Angioedema Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Hereditary Angioedema Drug Sales Volume Share, by Application (2017-2028)
-
Table China Hereditary Angioedema Drug Sales Value, by Application (2017-2028)
-
Table China Hereditary Angioedema Drug Sales Value Share, by Application (2017-2028)
-
Figure China Hereditary Angioedema Drug Sales Value Share, by Application (2017-2028)
-
Figure China Hereditary Angioedema Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Hereditary Angioedema Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Hereditary Angioedema Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Hereditary Angioedema Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Hereditary Angioedema Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Hereditary Angioedema Drug Sales Volume, by Type (2017-2028)
-
Table North America Hereditary Angioedema Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Hereditary Angioedema Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Hereditary Angioedema Drug Sales Volume, by Application (2017-2028)
-
Table North America Hereditary Angioedema Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Hereditary Angioedema Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Hereditary Angioedema Drug Sales Volume, by Type (2017-2028)
-
Table Europe Hereditary Angioedema Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Hereditary Angioedema Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Hereditary Angioedema Drug Sales Volume, by Application (2017-2028)
-
Table Europe Hereditary Angioedema Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Hereditary Angioedema Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Hereditary Angioedema Drug Sales Volume, by Type (2017-2028)
-
Table APAC Hereditary Angioedema Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Hereditary Angioedema Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Hereditary Angioedema Drug Sales Volume, by Application (2017-2028)
-
Table APAC Hereditary Angioedema Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Hereditary Angioedema Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Hereditary Angioedema Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Hereditary Angioedema Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Hereditary Angioedema Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Hereditary Angioedema Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Hereditary Angioedema Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Hereditary Angioedema Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Hereditary Angioedema Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Hereditary Angioedema Drug Sales Value and Growth Rate (2017-2028)
-
Table IBio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table IBio Inc Product Profiles, Application and Specification
-
Table IBio Inc Hereditary Angioedema Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CSL Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CSL Limited Product Profiles, Application and Specification
-
Table CSL Limited Hereditary Angioedema Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BioCryst Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BioCryst Pharmaceuticals, Inc Product Profiles, Application and Specification
-
Table BioCryst Pharmaceuticals, Inc Hereditary Angioedema Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pharming Group NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pharming Group NV Product Profiles, Application and Specification
-
Table Pharming Group NV Hereditary Angioedema Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shire plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shire plc Product Profiles, Application and Specification
-
Table Shire plc Hereditary Angioedema Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ionis Pharmaceuticals, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ionis Pharmaceuticals, Inc Product Profiles, Application and Specification
-
Table Ionis Pharmaceuticals, Inc Hereditary Angioedema Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
